Overview of ongoing and completed collaborative ERN GENTURIS research projects
Please see below for a list of ongoing research projects as well as a list of completed research projects in which at least two ERN GENTURIS HCPs from different countries are participating, and which are primarily led by an ERN GENTURIS member.
All ERN GENTURIS members as well as ERN GENTURIS ePAGs can present a project or an idea proposal or a study concept. For the procedure, see point 4 of the ERN GENTURIS rules of research governance.
Ongoing research projects
Completed research projects
Project title
|
Project leaders
|
Publication
|
Role of MCM8/9 variants in (colorectal) cancer predisposition
|
Dr. Maartje Nielsen, Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands |
pending |
CTNNA1 Variant Database
|
Dr. Carla Oliveira, i3S, Porto, Portugal |
pending |
Solve-RD - solving the unsolved rare diseases
|
Prof. Olaf Riess and Prof Holm Graessner, University of Tübingen, Tübingen, Germany |
List of Solve-RD publications
|
Cancer prognosis and treatment of PHTS patients
|
Dr. Janet Vos and Prof. Nicoline Hoogerbrugge, Radboudumc |
pending |
EU-PEARL (EU-Patient Centric Clinical Trial Platforms)
- WP Neurofibromatosis
|
Dr. Rianne Oostenbrink, ErasmusMC |
pending |
The multiple primary cancer phenotype of individuals with a biallelic pathogenic variant in CHEK2
|
Dr. Richarda de Voer and Prof. Nicoline Hoogerbrugge, Radboudumc |
doi.org/10.1016/j.gim.2024.101101
|
CDH1 Variant Database
|
Dr. Carla Oliveira, Porto Comprehensive Cancer Centre |
doi.org/10.1016/S1470-2045(22)00643-X
|
Finding the Missing Heritability in Lynch Syndrome: Germline Variant Analyses of Mismatch Repair Genes by Long-Read Single-molecule Real-time Sequencing
|
Dr. Richarda de Voer, Radboudumc |
doi.org/10.1053/j.gastro.2022.08.041
|
Estimations of diffuse gastric cancer risks in CTNNA1 pathogenic variants carriers
|
Dr. Chrystelle Colas, Institut Curie |
doi.org/10.1136/jmg-2022-108740
|
Unravelling the PHTS-associated variant spectrum
|
Dr. Janet Vos and Prof. Nicoline Hoogerbrugge, Radboudumc |
doi.org/10.1016/j.ejmg.2022.104632
|
Toward a more accurate cancer risk assessment in germline PTEN mutation carriers
|
Dr. Janet Vos and Prof. Nicoline Hoogerbrugge, Radboudumc |
doi.org/10.1093/jnci/djac188
|